Has Megan Wood, MD received payments from drug or device companies?

Yes. Drug and device makers reported $206,860 in general payments to Megan Wood, MD across 1,249 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Megan Wood, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Megan Wood, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Megan Wood, MD

Endocrinology, Diabetes & Metabolism · St. Louis, MONPI 1407052996

Payments from drug & device makers

$206,860in general payments, 2019–2025

Across 1,249 payments — averaging $165.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corcept Therapeutics$189K
Insulet Corporation$4K
Novo Nordisk$3K
AstraZeneca$2K
Xeris Pharmaceuticals, Inc.$1K
Abbott$1K
plus $7K from 40 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corcept Therapeutics	316	$189,173
Insulet Corporation	110	$3,539
Novo Nordisk	210	$3,012
AstraZeneca(2 entities)	56	$2,047
Xeris Pharmaceuticals, Inc.	58	$1,094
Abbott	75	$1,048
AbbVie	58	$857
Mannkind Corporation	61	$726
Lilly USA, LLC	36	$661
Bayer	32	$439
Antares Pharma, Inc.	31	$420
Amneal Pharmaceuticals LLC	20	$346
Endo Pharmaceuticals Inc.	14	$255
Tandem Diabetes Care, Inc.	16	$254
Recordati_rare_diseases_inc.	13	$250
Boehringer Ingelheim	13	$249
Radius Health, Inc.	11	$219
IBSA Pharma Inc.	12	$195
Amarin Pharma, Inc.	12	$175
Sanofi-aventis U.S. LLC	9	$152
Merck	7	$130
Verity Pharmaceuticals Inc.	3	$124
Pylant Medical	1	$122
Dexcom, Inc.	7	$120
Aimmune Therapeutics, Inc.	6	$117
Esperion Therapeutics, Inc.	6	$115
Amgen(2 entities)	6	$112
BETA Bionics, Inc.	7	$103
Medtronic(2 entities)	6	$98
Sequel Med Tech, LLC	4	$77
Amryt Pharma Holdings Ltd	4	$76
Nestle Healthcare Nutrition Inc.	4	$74
Clarus Therapeutics Inc.	4	$69
Madrigal Pharmaceuticals	3	$65
Novartis	3	$61
Halozyme Inc	3	$56
Amphastar Pharmaceuticals, Inc.	2	$42
Optos, Inc.	2	$41
Ultragenyx Pharmaceutical Inc.	1	$23
Ascensia Diabetes Care US Inc.	1	$21
Ascendis Pharma Endocrinology Inc	1	$21
Exeltis, USA Inc.	1	$18
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$17
Sanofi	1	$17
BD	1	$15
Currax Pharmaceuticals LLC	1	$15

How this compares

$206,860 in reported general payments places this provider in the 90th percentile of 182 endocrinology, diabetes & metabolism providers in Missouri.

See all endocrinology, diabetes & metabolism providers in Missouri →

Medicare billing

Part B allowed, 2024

$33,764

Medicare patients

Services billed

370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in St. Louis

Ralph DudaSpringfield$3M
Thomas NickolasSaint Louis$945K
Anne GoldbergSaint Louis$830K
Janet McGillSaint Louis$828K
Christopher CaseJefferson City$692K
Gregory LedgerSpringfield$690K
Karen Chang-ChenChesterfield$640K
Alan RaubaJefferson City$594K
Julie SilversteinSaint Louis$536K
Ralph OiknineChesterfield$414K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →